{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-014809","form_type":"8-K","ticker":"ERNA","cik":"0000748592","company_name":"Ernexa Therapeutics Inc.","filed_at":"2024-03-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.858638+00:00","generated_at":"2026-06-04T09:23:00.767271+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Eterna Therapeutics receives Nasdaq delisting notice for stockholders' equity below $2.5M minimum","bullets":["Stockholders' equity was $2.2M as of Dec 31, 2024, below the $2.5M minimum required by Nasdaq Listing Rule 5550(b)(1).","Company must submit a compliance plan to Nasdaq by May 3, 2024.","If plan accepted, Nasdaq may grant up to 180-day extension to regain compliance.","No immediate effect on listing; common stock continues trading under ERNA."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-014809","json":"https://secwatch.observer/filing/0001140361-24-014809.json","markdown":"https://secwatch.observer/filing/0001140361-24-014809.md","text":"https://secwatch.observer/filing/0001140361-24-014809.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/748592/000114036124014809/0001140361-24-014809-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/748592/000114036124014809/ef20024913_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T09:23:00.767271+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}